Click Here to Get Started

advertisement
Adopt Help Adopt Help Adopt Help
advertisement
Click Here to Get Started

Aspergillosis

  • Currently 0/5 Stars.
You may use the stars on the left to rate and leave feedback for the current article. No registration is required. Waiting for 5 votes 0.0 of 5 stars (0 votes) — Thanks for your vote

Please fill out the following optional information before submitting your rating:



Clinical Features
In immunosuppressed hosts: invasive pulmonary infection, usually with fever, cough, and chest pain. May disseminate to other organs, including brain, skin and bone. In immunocompetent hosts: localized pulmonary infection in persons with underlying lung disease. Also causes allergic sinusitis and allergic bronchopulmonary disease.

Etiologic Agent
Aspergillus fumigatus, A. flavus. Less commonly A. terreus, A. nidulans, A. niger.

advertisement
 

Reservoir
Ubiquitous in the environment. Found in soil, decomposing plant matter, household dust, building materials, ornamental plants, items of food, and water.

Incidence
Not reportable. Population-based data available for San Francisco suggest a rate of 1-2 per 100,000 per year.

Sequelae
If severe granulocytopenia persists, mortality rate can be very high (up to 100% in patients with cerebral abscesses). Patient outcome depends on resolution of granulocytopenia and early institution of effective antifungal drug therapy.

Transmission
Inhalation of airborne conidia (spores). Nosocomial infection may be associated with dust exposure during building renovation or construction. Occasional outbreaks of cutaneous infection traced to contaminated biomedical devices.

Risk Groups
Persons with severe, prolonged granulocytopenia (e.g., hematologic malignancy, hematopoietic stem cell and solid organ transplant recipients, and patients on high-dose corticosteroids). Rarely, persons with HIV infection.

Surveillance
No national surveillance exists. Active surveillance is being conducted among hematopoietic stem cell and solid organ transplant recipients in selected U.S. hospitals.

Challenges
Identifying modifiable risk factors for disease in immunocompromised persons. Improving understanding of sources and routes of transmission from the environment. Developing sensitive and specific methods for earlier diagnosis.

Opportunities
Development of rapid antigenemia and antigenuria tests and molecular probes may facilitate earlier clinical diagnosis. Availability of improved molecular typing methods may assist in epidemiologic studies.

Related Topics
(866) 569-2229
California
Click here to visit A is 4 Adoption
Adoption is a courageous act of love. Why A is 4 Adoption? We are a "hands on" organization with a passion for creating families. Let us take the worry out of your adoption.
A is 4 Adoption
(714) 556-0220   (866) 569-2229
advertisement
Sponsored Links
Parent Profiles
"LOVE-a profoundly tender affection for another." Take a look & learn more about us and our love for adoption. [more]

[about us]  [contact us]  [waiting couples near CA]  [all]

Adoption Tips
Before you can adopt internationally, you will need to obtain approval from the U.S. Citizenship and Immigration Services.
Adoption Photolisting
Elijah (CA / 15 / M)
Elijah is a happy and easygoing kind of guy! He enjoys the company of those he knows and recognizes. Although he has difficulty communicating, he can demonstrate his content with... [more]

[about me]   [search]   [waiting kids in CA]   [all]   [share]

Adoption E-Magazine
Help
Feedback
Template Settings
Width: 1024     1280
Choose a Location:
Choose a Theme: